Sua seleção (0)
Detalhe da pesquisa
1.
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
Blood;
131(16): 1820-1832, 2018 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29358183
2.
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
Blood;
132(16): 1664-1674, 2018 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185431
3.
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
2019 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518645
4.
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients.
Br J Haematol;
187(3): 307-318, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243771
5.
Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments.
Br J Haematol;
185(5): 852-864, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924136
6.
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
Am J Hematol;
94(7): 757-766, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963592
7.
TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.
Ann Diagn Pathol;
41: 38-42, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132650
8.
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.
Biol Blood Marrow Transplant;
24(7): 1514-1520, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448058
9.
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
Cancer;
2018 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30508305
10.
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
Cancer;
124(13): 2704-2713, 2018 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682723
11.
Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation.
Mod Pathol;
2018 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323237
12.
Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience.
Mod Pathol;
31(11): 1717-1732, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955146
13.
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors.
Blood;
127(10): 1269-75, 2016 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26729897
14.
Persistent IDH1/2 mutation in remission can predict relapse in patients with acute myeloid leukemia.
Haematologica;
2018 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171025
15.
The co-occurrence of driver mutations in chronic myeloproliferative neoplasms.
Ann Hematol;
97(11): 2071-2080, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29951914
16.
Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Eur J Haematol;
100(5): 444-454, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385279
17.
Unique Case of Myeloproliferative Neoplasm with Two Rare Clonal Abnormalities: Rare JAK2 Exon 12 Mutation and Rare e14a3 (b3a3) BCR/ABL Fusion Transcript.
Acta Haematol;
141(1): 23-27, 2018 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30463063
18.
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
Cancer;
123(19): 3717-3724, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608976
19.
Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma.
Br J Haematol;
178(3): 403-412, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28382648
20.
Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.
Mod Pathol;
30(10): 1338-1366, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664939